Search

everythinglearnresearchcommunity

for

Search:↓

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Slug is crucial for skin health, hair growth, and healing.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

DRDE-07 shows promise for treating skin diseases due to its favorable properties.

5α-reductase 2 is crucial for stress response in male rats.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

ANE syndrome is caused by a mutation in the RBM28 protein that disrupts ribosome assembly.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Understanding snoRNA regulation may help slow skin aging.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Repetin is a protein involved in skin and hair development, binding calcium and compensating for other proteins when needed.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

RXRα is crucial for proper immune response and links diet to immune function.

Researchers found two new genetic variants linked to Alzheimer's disease.

KRT14 gene variants cause dermatopathia pigmentosa reticularis, affecting nails, teeth, and hair.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

PrrH sRNA controls pyochelin gene expression in Pseudomonas aeruginosa based on heme levels.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

A second domain of high sulfur KAP genes on chromosome 21q23 is crucial for hair structure.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.